Calton & Associates, Inc. Palatin Technologies Inc Transaction History

Calton & Associates, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	BUY	$0.37 - $0.54 $2,220 - $3,240	6,000 Added 25.0%	30,000 $13,000
Q4 2021 Jan 13, 2022	SELL	$0.34 - $0.86 $3,400 - $8,600	-10,000 Reduced 29.41%	24,000 $12,000
Q2 2020 Aug 10, 2020	SELL	$0.41 - $0.73 $48 - $86	-119 Reduced 0.35%	34,000 $17,000
Q1 2020 Apr 30, 2020	BUY	$0.36 - $0.79 $5,040 - $11,060	14,000 Added 69.59%	34,119 $14,000
Q4 2019 Feb 03, 2020	BUY	$0.75 - $0.89 $15,089 - $17,905	20,119 New	20,119 $16,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.4M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.